momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (6901)	4/10/2008 8:37:47 AM
From: rkrw	Read Replies (1) of 12215

Seeking alpha comments on Merrill side: <<<Merrill saying AMAG Pharmaceuticals (AMAG) is worth $21 to $29. They now see potential for a delayed launch until 2011. This thing could be down 10%+ today. One Notablecalls Network [NCN] member has some interesting comments on the AMAG downgrade: It's the third time he has downgraded it in 10 weeks - first Jan. 30 then Feb 28 and now [today]. Nothing new in the report. Also the analyst was hired by Merrill only last year and I think the guy's trying to make a name for himself. Jan. 30 he went from a $100 target to $78 and the stock fell 6 points. Than Feb. 28 he went to Neutral and the stock fell $4 I think. I'm just saying the whole street knows he has it out for AMAG. Notablecalls: Excellent color.>>> Seems the stock will remain controversial and jerked around until the pdufa date and possible approval/setback. If approved, then they can fight about the market size.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next